The antimicrobial peptide LL-37 inhibits HIV-1 replication.

Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab (2008) 4.61

Antibacterial effects of vitamin D. Nat Rev Endocrinol (2011) 2.03

Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract (2009) 1.93

Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun (2008) 1.77

Vitamin D and the intracrinology of innate immunity. Mol Cell Endocrinol (2010) 1.50

Hormonally active vitamin D3 (1alpha,25-dihydroxycholecalciferol) triggers autophagy in human macrophages that inhibits HIV-1 infection. J Biol Chem (2011) 1.48

Vitamin D3: a helpful immuno-modulator. Immunology (2011) 1.46

Vitamin D and the anti-viral state. J Clin Virol (2011) 1.40

Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS One (2011) 1.39

Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biol Reprod (2008) 1.37

Human antimicrobial peptides and proteins. Pharmaceuticals (Basel) (2014) 1.23

Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins. Antimicrob Agents Chemother (2008) 1.20

Host defense peptides in the oral cavity and the lung: similarities and differences. J Dent Res (2008) 1.19

Vitamin D metabolism and innate immunity. Mol Cell Endocrinol (2011) 1.11

Vitamin D in HIV-Infected Patients. Curr HIV/AIDS Rep (2011) 1.11

Low serum 25-hydroxyvitamin D level and risk of upper respiratory tract infection in children and adolescents. Clin Infect Dis (2013) 1.09

Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database. Antimicrob Agents Chemother (2010) 1.08

High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments. Biochim Biophys Acta (2014) 1.05

Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American women. Osteoporos Int (2010) 1.03

Risk factors for vitamin D deficiency and relationship with cardiac biomarkers, inflammation and immune restoration in HIV-infected youth. Antivir Ther (2012) 1.03

5' regulatory and 3' untranslated region polymorphisms of vitamin D receptor gene in south Indian HIV and HIV-TB patients. J Clin Immunol (2008) 1.02

The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins. J Gen Virol (2012) 0.98

HIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationships. PLoS One (2012) 0.94

Susceptibility to infectious diseases based on antimicrobial peptide production. Infect Immun (2009) 0.94

HIV acquisition is associated with increased antimicrobial peptides and reduced HIV neutralizing IgA in the foreskin prepuce of uncircumcised men. PLoS Pathog (2014) 0.92

Cationic host defence peptides: potential as antiviral therapeutics. BioDrugs (2013) 0.92

The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus. PLoS One (2013) 0.88

Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cells. J Virol (2012) 0.88

Can we translate vitamin D immunomodulating effect on innate and adaptive immunity to vaccine response? Nutrients (2015) 0.87

Cross-sectional study of vitamin D levels, immunologic and virologic outcomes in HIV-infected adults. J Clin Endocrinol Metab (2013) 0.83

How important is vitamin D in preventing infections? Osteoporos Int (2012) 0.82

Cathelicidin antimicrobial protein, vitamin D, and risk of death in critically ill patients. Crit Care (2015) 0.82

Vitamin D deficiency and altered bone mineral metabolism in HIV-infected individuals. Curr HIV/AIDS Rep (2014) 0.79

Upregulation of human β-defensin-3 and cathelicidin LL-37 in Kaposi's sarcoma. F1000Res (2012) 0.77

Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected Women. J Acquir Immune Defic Syndr (2015) 0.77

LL-37 concentrations and the relationship to vitamin D, immune status, and inflammation in HIV-infected children and young adults. AIDS Res Hum Retroviruses (2014) 0.76

Short communication: High prevalence of vitamin D deficiency in HIV-infected and HIV-uninfected pregnant women. AIDS Res Hum Retroviruses (2013) 0.76

Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells. BMC Res Notes (2016) 0.75

The Role of Antimicrobial Peptides in Influenza Virus Infection and Their Potential as Antiviral and Immunomodulatory Therapy. Pharmaceuticals (Basel) (2016) 0.75

Maternal vitamin D supplementation during pregnancy and lactation to prevent acute respiratory infections in infancy in Dhaka, Bangladesh (MDARI trial): protocol for a prospective cohort study nested within a randomized controlled trial. BMC Pregnancy Childbirth (2016) 0.75

The Human Antimicrobial Protein Bactericidal/Permeability-Increasing Protein (BPI) Inhibits the Infectivity of Influenza A Virus. PLoS One (2016) 0.75

Amniotic fluid exhibits an innate inhibitory activity against HIV type 1 replication in vitro. AIDS Res Hum Retroviruses (2012) 0.75

Natural antimicrobial peptides as promising anti-HIV candidates. Curr Top Pept Protein Res (2016) 0.75

Autonomous immunity in mucosal epithelial cells: fortifying the barrier against infection. Microbes Infect (2016) 0.75

The Role of Cationic Polypeptides in Modulating HIV-1 Infection of the Cervicovaginal Mucosa. Antibiotics (Basel) (2014) 0.75

Evaluation of vitamin D level in patients from neurosurgical intensive care unit. Neural Regen Res (2013) 0.75

Vitamin D-Regulated MicroRNAs: Are They Protective Factors against Dengue Virus Infection? Adv Virol (2016) 0.75

Potential Use of Antimicrobial Peptides as Vaginal Spermicides/Microbicides. Pharmaceuticals (Basel) (2016) 0.75

Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat. Int J Pept (2012) 0.75

Prevalence of common vitamin D receptor gene polymorphisms in HIV-infected and uninfected South Africans. Int J Mol Epidemiol Genet (2016) 0.75

Methylation of the Vitamin D Receptor (VDR) Gene, Together with Genetic Variation, Race, and Environment Influence the Signaling Efficacy of the Toll-Like Receptor 2/1-VDR Pathway. Front Immunol (2017) 0.75

The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med (2006) 5.20

Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med (2012) 3.27

HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. AIDS (2008) 2.67

Clinical utility of PCR for common viruses in acute respiratory illness. Pediatrics (2014) 1.86

Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatr Res (2003) 1.86

Neutrophil-derived cathelicidin protects from neointimal hyperplasia. Sci Transl Med (2011) 1.84

CD46 in meningococcal disease. Science (2003) 1.84

Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc Natl Acad Sci U S A (2006) 1.75

Cervicovaginal HIV-1-neutralizing immunoglobulin A detected among HIV-1-exposed seronegative female partners in HIV-1-discordant couples. AIDS (2012) 1.64

Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition. AIDS (2009) 1.64

Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy. Clin Infect Dis (2008) 1.55

Prolonged activation of virus-specific CD8+T cells after acute B19 infection. PLoS Med (2005) 1.53

Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects. J Acquir Immune Defic Syndr (2002) 1.45

Induction of the antimicrobial peptide CRAMP in the blood-brain barrier and meninges after meningococcal infection. Infect Immun (2006) 1.41

Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog (2010) 1.41

Detection of human parvovirus B19 infection in first-trimester fetal loss. Obstet Gynecol (2002) 1.40

Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study. BMJ Open (2012) 1.34

Antimicrobial peptides important in innate immunity. FEBS J (2011) 1.30

Neutrophil primary granule proteins HBP and HNP1-3 boost bacterial phagocytosis by human and murine macrophages. J Clin Invest (2008) 1.25

Antimicrobial peptides in the first line defence of human colon mucosa. Peptides (2003) 1.24

The role of the multifunctional peptide LL-37 in host defense. Front Biosci (2008) 1.23

Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37. Cell Microbiol (2005) 1.22

Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans. Infect Immun (2008) 1.21

Phenylbutyrate induces antimicrobial peptide expression. Antimicrob Agents Chemother (2009) 1.21

Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition. AIDS (2009) 1.21

Expression and activity of beta-defensins and LL-37 in the developing human lung. J Immunol (2005) 1.17

Abundant expression of HIV target cells and C-type lectin receptors in the foreskin tissue of young Kenyan men. Am J Pathol (2010) 1.13

Upregulation of interferon-alpha and RANTES in the cervix of HIV-1-seronegative women with high-risk behavior. J Acquir Immune Defic Syndr (2006) 1.09

Involvement of the antimicrobial peptide LL-37 in human atherosclerosis. Arterioscler Thromb Vasc Biol (2006) 1.09

Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41. AIDS (2002) 1.09

Slow clearance of human parvovirus B19 viremia following acute infection. Clin Infect Dis (2005) 1.08

Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1. FASEB J (2011) 1.07

Abundant and superficial expression of C-type lectin receptors in ectocervix of women at risk of HIV infection. J Acquir Immune Defic Syndr (2009) 1.05

Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia: a potential therapeutic strategy. PLoS One (2011) 1.04

Antibacterial peptides in stimulated human granulocytes: characterization of ubiquitinated histone H1A. Eur J Biochem (2002) 1.02

Human-like immune responses in CD46 transgenic mice. J Immunol (2005) 1.00

Induction of the human cathelicidin LL-37 as a novel treatment against bacterial infections. J Leukoc Biol (2012) 0.99

Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humans. J Virol (2005) 0.98

A systems biology examination of the human female genital tract shows compartmentalization of immune factor expression. J Virol (2013) 0.97

Antimicrobial components of the neonatal gut affected upon colonization. Pediatr Res (2007) 0.96

Oral HIV-exposure elicits mucosal HIV-neutralizing antibodies in uninfected men who have sex with men. AIDS (2009) 0.95

Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity. J Immunol (2004) 0.95

Detection of intraepithelial and stromal Langerin and CCR5 positive cells in the human endometrium: potential targets for HIV infection. PLoS One (2011) 0.95

Induction of systemic HIV-1-specific cellular immune responses by oral exposure in the uninfected partner of discordant couples. AIDS (2010) 0.94

HIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationships. PLoS One (2012) 0.94

Human glutaredoxin-1 catalyzes the reduction of HIV-1 gp120 and CD4 disulfides and its inhibition reduces HIV-1 replication. Int J Biochem Cell Biol (2008) 0.94

In situ distribution of HIV-binding CCR5 and C-type lectin receptors in the human endocervical mucosa. PLoS One (2011) 0.94

Preparation of 3-substituted-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amines as RET kinase inhibitors. J Med Chem (2012) 0.94

The cathelicidins LL-37 and rCRAMP are associated with pathogenic events of arthritis in humans and rats. Ann Rheum Dis (2012) 0.93

Active, fulminant, lethal myocarditis associated with parvovirus B19 infection in an infant. Clin Infect Dis (2002) 0.92

Respiratory viruses, a common microbiological finding in neutropenic children with fever. J Clin Virol (2010) 0.92

Leukotriene B4 triggers release of the cathelicidin LL-37 from human neutrophils: novel lipid-peptide interactions in innate immune responses. FASEB J (2007) 0.92

PU.1 and bacterial metabolites regulate the human gene CAMP encoding antimicrobial peptide LL-37 in colon epithelial cells. Mol Immunol (2008) 0.91

Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis. BMC Pulm Med (2013) 0.91

Parvovirus B19 infection. Semin Fetal Neonatal Med (2009) 0.90

The antimicrobial peptide rCRAMP is present in the central nervous system of the rat. J Neurochem (2005) 0.89

Specificity in killing pathogens is mediated by distinct repertoires of human neutrophil peptides. J Innate Immun (2010) 0.89

Phenylbutyrate induces cathelicidin expression via the vitamin D receptor: Linkage to inflammatory and growth factor cytokines pathways. Mol Immunol (2015) 0.88

Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial. BMC Infect Dis (2012) 0.88

Flocked nasal swab versus nasopharyngeal aspirate for detection of respiratory tract viruses in immunocompromised adults: a matched comparative study. BMC Infect Dis (2010) 0.87

Proteome analysis of vernix caseosa. Pediatr Res (2006) 0.87

HIV-1 neutralizing activity is correlated with increased levels of chemokines in saliva of HIV-1-exposed uninfected individuals. Curr HIV Res (2008) 0.87

Stable CD4 expression and local immune activation in the ectocervical mucosa of HIV-infected women. J Immunol (2013) 0.86

Antibacterial activities of the cathelicidins prophenin (residues 62 to 79) and LL-37 in the presence of a lung surfactant preparation. Antimicrob Agents Chemother (2004) 0.86

Human parvovirus B19 DNA is not detected in Guthrie cards from children who have developed acute lymphoblastic leukemia. Pediatr Blood Cancer (2004) 0.86

Isolation and identification of antimicrobial components from the epidermal mucus of Atlantic cod (Gadus morhua). FEBS J (2005) 0.85

Mannose-binding lectin 2 polymorphisms do not influence frequency or type of infection in adults with chemotherapy induced neutropaenia. PLoS One (2012) 0.85

The antimicrobial peptide LL-37 binds to the human plasma protein apolipoprotein A-I. Rapid Commun Mass Spectrom (2004) 0.85

No difference in keratin thickness between inner and outer foreskins from elective male circumcisions in Rakai, Uganda. PLoS One (2012) 0.85

A genetic polymorphism of FREM1 is associated with resistance against HIV infection in the Pumwani sex worker cohort. J Virol (2012) 0.85

Viral findings in adult hematological patients with neutropenia. PLoS One (2012) 0.85

Slumbering mucosal immune response in the cervix of human papillomavirus DNA-positive and -negative women. Int J Oncol (2010) 0.85

Cathelicidin LL-37 induces angiogenesis via PGE2-EP3 signaling in endothelial cells, in vivo inhibition by aspirin. Arterioscler Thromb Vasc Biol (2013) 0.84

Battle and balance at mucosal surfaces--the story of Shigella and antimicrobial peptides. Biochem Biophys Res Commun (2010) 0.84

Genital immunoglobulin A and HIV-1 protection: virus neutralization versus specificity. AIDS (2008) 0.84

Salivary basic proline-rich proteins are elevated in HIV-exposed seronegative men who have sex with men. AIDS (2012) 0.84

First line of defense in early human life. Semin Perinatol (2004) 0.83

Persistence of human parvovirus B19 in multipotent mesenchymal stromal cells expressing the erythrocyte P antigen: implications for transplantation. Biol Blood Marrow Transplant (2008) 0.83

Treatment with phenylbutyrate in a pre-clinical trial reduces diarrhea due to enteropathogenic Escherichia coli: link to cathelicidin induction. Microbes Infect (2013) 0.82

Lactose in human breast milk an inducer of innate immunity with implications for a role in intestinal homeostasis. PLoS One (2013) 0.82

Orally exposed uninfected individuals have systemic anti-HIV responses associating with partners' viral load. AIDS (2010) 0.82

Parvovirus B19 capsid protein VP2 inhibits hematopoiesis in vitro and in vivo: implications for therapeutic use. Exp Hematol (2004) 0.81

HIV-1 exposed uninfected men who have sex with men have increased levels of salivary CC-chemokines associated with sexual behavior. AIDS (2010) 0.80

A review of the innate immune defence of the human foetus and newborn, with the emphasis on antimicrobial peptides. Acta Paediatr (2014) 0.80

Impaired release of antimicrobial peptides into nasal fluid of hyper-IgE and CVID patients. PLoS One (2011) 0.80

Presence of HIV-1 neutralizing IgA antibodies in primary HIV-1 infected patients. Scand J Infect Dis (2004) 0.80

High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients. J Clin Virol (2005) 0.80

Boosting innate immunity: development and validation of a cell-based screening assay to identify LL-37 inducers. Innate Immun (2013) 0.79

Presence of CD8+ T cells in the ectocervical mucosa correlates with genital viral shedding in HIV-infected women despite a low prevalence of HIV RNA-expressing cells in the tissue. J Immunol (2014) 0.79

Aberrant cellular immune responses in humans infected persistently with parvovirus B19. J Med Virol (2006) 0.79

Plasma and mucosal fluid from HIV type 1-infected patients but not from HIV type 1-exposed uninfected subjects prevent HIV type 1-exposed DC from infecting other target cells. AIDS Res Hum Retroviruses (2007) 0.78

T lymphocyte responses against human parvovirus B19: small virus, big response. Pathol Biol (Paris) (2002) 0.78

Characterization of biofilm formation and the role of BCR1 in clinical isolates of Candida parapsilosis. Eukaryot Cell (2013) 0.77

Revised clinical presentation of parvovirus B19-associated intrauterine fetal death. Clin Infect Dis (2002) 0.77

Cod cathelicidin: isolation of the mature peptide, cleavage site characterisation and developmental expression. Dev Comp Immunol (2010) 0.77

Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected Women. J Acquir Immune Defic Syndr (2015) 0.77

Differential host immune responses to epidemic and endemic strains of Shigella dysenteriae type I. J Health Popul Nutr (2011) 0.77

Detection of parvovirus B19, cytomegalovirus and enterovirus infections in cases of intrauterine fetal death. J Perinat Med (2004) 0.76